Please login to the form below

Not currently logged in
Email:
Password:

paroxetine

This page shows the latest paroxetine news and features for those working in and with pharma, biotech and healthcare.

Concordia accused of overcharging NHS for thyroid drug

Concordia accused of overcharging NHS for thyroid drug

ruling. Meanwhile, earlier in 2016 the CMA fined number of pharmaceutical companies in relation to ‘pay-for-delay’deals that affected the supply of generic paroxetine, an antidepressant developed by GlaxoSmithKline.

Latest news

  • UK government fines GSK over 'pay-for-delay' deals UK government fines GSK over 'pay-for-delay' deals

    When generics finally entered the market in 2003, average paroxetine prices dropped by more than 70% within two years. ... The UK's Office of Fair Trading (OFT) formally accused GSK of delaying generic paroxetine sales back in 2013.

  • GSK holds on to older products GSK holds on to older products

    £185m. Other products in GSK's established portfolio with declining sales include antidepressant Seroxat/Paxil (paroxetine) and antiviral drug Valtrex (valacyclovir), both of which had a double digit fall in revenues

  • GSK plans to sell off older products GSK plans to sell off older products

    Imitrex (sumatriptan) for migraine, the antidepressant Paxil/Seroxat (paroxetine) and gastrointestinal therapy Zantac (ranitidine) have all been named in dispatches as former blockbuster brands that are now in GSK's 'established

  • GSK to hire doctors as product champions GSK to hire doctors as product champions

    GSK has undertaken a major overhaul of its commercial operations since it agreed a $3bn settlement in the US in 2012 amid allegations of illegal marketing practices for antidepressants Paxil (paroxetine)

  • Hisamitsu's Noven unit signs Brisdelle deal with Shionogi Hisamitsu's Noven unit signs Brisdelle deal with Shionogi

    Noven is to co-promote its menopausal hot flushes treatment Brisdelle (paroxetine) with Shionogi. ... Brisdelle contains 7.5mg of paroxetine, which - at a slightly higher dose - is the active ingredient in antidepressants like GlaxoSmithKline's now

More from news
Approximately 1 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics